Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network (2018) Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, et al. Journal article, Review article CAR T-cells targeting FLT3 have potent activity against FLT3-ITD+AML and act synergistically with the FLT3-inhibitor crenolanib (2018) Jetani H, Garcia-Cadenas I, Nerreter T, Thomas S, Rydzek J, Briones Meijide J, Bonig H, et al. Journal article JAM-A as a prognostic factor and new therapeutic target in multiple myeloma (2018) Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stuehmer T, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV (2018) Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, et al. Journal article Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway (2018) Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, et al. Journal article Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT (2017) Neuenhahn M, Albrecht J, Odendahl M, Schlott F, Doessinger G, Schiemann M, Lakshmipathi S, et al. Journal article Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL (2017) Duell J, Dittrich M, Bedke T, Mueller T, Eisele F, Rosenwald A, Rasche L, et al. Journal article IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: A study of the German Myeloma Study Group (DSMM) (2017) Kroenke J, Kuchenbauer F, Kull M, Teleanu V, Bullinger L, Bunjes D, Greiner A, et al. Journal article The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia. (2017) Qorraj M, Bruns H, Böttcher M, Weigand L, Saul D, Mackensen A, Jitschin R, Mougiakakos D Journal article